Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy

Authors

María Belén Ortega-García, Instituto de Investigación Biosanitaria ibs.GRANADA
Igor Zwir, Washington University School of Medicine in St. Louis
et al

Journal

Cancers (Basel)

Publication Date

2020

Volume

12

Issue

2

First Page

379

Document Type

Open Access Publication

DOI

10.3390/cancers12020379

Rights and Permissions

Ortega-García MB, Mesa A, Moya EL, Rueda B, Lopez-Ordoño G, García JÁ, Conde V, Redondo-Cerezo E, Lopez-Hidalgo JL, Jiménez G, Peran M, Martínez-González LJ, del Val C, Zwir I, Marchal JA, García MÁ. Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy. Cancers. 2020; 12(2):379. doi: 10.3390/cancers12020379.

Recommended Citation

Ortega-García, María Belén; Zwir, Igor; and et al, "Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy." Cancers (Basel). 12, 2. 379 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8797